Literature DB >> 30339406

Transition-State Analogues of Campylobacter jejuni 5'-Methylthioadenosine Nucleosidase.

Rodrigo G Ducati1, Rajesh K Harijan1, Scott A Cameron1, Peter C Tyler2, Gary B Evans2,3, Vern L Schramm1.   

Abstract

Campylobacter jejuni is a Gram-negative bacterium responsible for food-borne gastroenteritis and associated with Guillain-Barré, Reiter, and irritable bowel syndromes. Antibiotic resistance in C. jejuni is common, creating a need for antibiotics with novel mechanisms of action. Menaquinone biosynthesis in C. jejuni uses the rare futalosine pathway, where 5'-methylthioadenosine nucleosidase ( CjMTAN) is proposed to catalyze the essential hydrolysis of adenine from 6-amino-6-deoxyfutalosine to form dehypoxanthinylfutalosine, a menaquinone precursor. The substrate specificity of CjMTAN is demonstrated to include 6-amino-6-deoxyfutalosine, 5'-methylthioadenosine, S-adenosylhomocysteine, adenosine, and 5'-deoxyadenosine. These activities span the catalytic specificities for the role of bacterial MTANs in menaquinone synthesis, quorum sensing, and S-adenosylmethionine recycling. We determined inhibition constants for potential transition-state analogues of CjMTAN. The best of these compounds have picomolar dissociation constants and were slow-onset tight-binding inhibitors. The most potent CjMTAN transition-state analogue inhibitors inhibited C. jejuni growth in culture at low micromolar concentrations, similar to gentamicin. The crystal structure of apoenzyme C. jejuni MTAN was solved at 1.25 Å, and five CjMTAN complexes with transition-state analogues were solved at 1.42 to 1.95 Å resolution. Inhibitor binding induces a loop movement to create a closed catalytic site with Asp196 and Ile152 providing purine leaving group activation and Arg192 and Glu12 activating the water nucleophile. With inhibitors bound, the interactions of the 4'-alkylthio or 4'-alkyl groups of this inhibitor family differ from the Escherichia coli MTAN structure by altered protein interactions near the hydrophobic pocket that stabilizes 4'-substituents of transition-state analogues. These CjMTAN inhibitors have potential as specific antibiotic candidates against C. jejuni.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 30339406      PMCID: PMC6568325          DOI: 10.1021/acschembio.8b00781

Source DB:  PubMed          Journal:  ACS Chem Biol        ISSN: 1554-8929            Impact factor:   5.100


  51 in total

Review 1.  The depth of chemical time and the power of enzymes as catalysts.

Authors:  R Wolfenden; M J Snider
Journal:  Acc Chem Res       Date:  2001-12       Impact factor: 22.384

Review 2.  Human campylobacteriosis: a challenge for the veterinary profession.

Authors:  Sean F Altekruse; Linda K Tollefson
Journal:  J Am Vet Med Assoc       Date:  2003-08-15       Impact factor: 1.936

3.  The enzymatic synthesis of S-adenosyl-L-homocysteine from adenosine and homocysteine.

Authors:  G DE LA HABA; G L CANTONI
Journal:  J Biol Chem       Date:  1959-03       Impact factor: 5.157

4.  The enzymatic decomposition of S-adenosyl-L-methionine.

Authors:  S K SHAPIRO; A N MATHER
Journal:  J Biol Chem       Date:  1958-09       Impact factor: 5.157

5.  Acyl homoserine-lactone quorum-sensing signal generation.

Authors:  M R Parsek; D L Val; B L Hanzelka; J E Cronan; E P Greenberg
Journal:  Proc Natl Acad Sci U S A       Date:  1999-04-13       Impact factor: 11.205

6.  Structure of E. coli 5'-methylthioadenosine/S-adenosylhomocysteine nucleosidase reveals similarity to the purine nucleoside phosphorylases.

Authors:  J E Lee; K A Cornell; M K Riscoe; P L Howell
Journal:  Structure       Date:  2001-10       Impact factor: 5.006

7.  Substrate specificity of 5'-methylthioadenosine phosphorylase from human prostate.

Authors:  V Zappia; A Oliva; G Cacciapuoti; P Galletti; G Mignucci; M Cartení-Farina
Journal:  Biochem J       Date:  1978-12-01       Impact factor: 3.857

8.  Exploring structure-activity relationships of transition state analogues of human purine nucleoside phosphorylase.

Authors:  Gary B Evans; Richard H Furneaux; Andrzej Lewandowicz; Vern L Schramm; Peter C Tyler
Journal:  J Med Chem       Date:  2003-07-17       Impact factor: 7.446

9.  Synthesis of a transition state analogue inhibitor of purine nucleoside phosphorylase via the Mannich reaction.

Authors:  Gary B Evans; Richard H Furneaux; Peter C Tyler; Vern L Schramm
Journal:  Org Lett       Date:  2003-10-02       Impact factor: 6.005

10.  Targeting the polyamine pathway with transition-state analogue inhibitors of 5'-methylthioadenosine phosphorylase.

Authors:  Gary B Evans; Richard H Furneaux; Vern L Schramm; Vipender Singh; Peter C Tyler
Journal:  J Med Chem       Date:  2004-06-03       Impact factor: 7.446

View more
  4 in total

1.  Antibacterial Strategy against H. pylori: Inhibition of the Radical SAM Enzyme MqnE in Menaquinone Biosynthesis.

Authors:  Sumedh Joshi; Dmytro Fedoseyenko; Nilkamal Mahanta; Rodrigo G Ducati; Mu Feng; Vern L Schramm; Tadhg P Begley
Journal:  ACS Med Chem Lett       Date:  2019-02-15       Impact factor: 4.345

2.  Characterization of 5'-methylthioadenosine/S-adenosylhomocysteine nucleosidases from Borrelia burgdorferi: Antibiotic targets for Lyme disease.

Authors:  Kenneth A Cornell; Reece J Knippel; Gerald R Cortright; Meghan Fonken; Christian Guerrero; Amy R Hall; Kristen A Mitchell; John H Thurston; Patrick Erstad; Aoxiang Tao; Dong Xu; Nikhat Parveen
Journal:  Biochim Biophys Acta Gen Subj       Date:  2019-10-31       Impact factor: 3.770

3.  Inverse heavy enzyme isotope effects in methylthioadenosine nucleosidases.

Authors:  Morais Brown; Ioanna Zoi; Dimitri Antoniou; Hilda A Namanja-Magliano; Steven D Schwartz; Vern L Schramm
Journal:  Proc Natl Acad Sci U S A       Date:  2021-10-05       Impact factor: 11.205

4.  Bioinformatic Assessment of Factors Affecting the Correlation between Protein Abundance and Elongation Efficiency in Prokaryotes.

Authors:  Aleksandra E Korenskaia; Yury G Matushkin; Sergey A Lashin; Alexandra I Klimenko
Journal:  Int J Mol Sci       Date:  2022-10-09       Impact factor: 6.208

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.